Mean ± SD | 354 | ±107.94 | Mean ± SD | 52.20 | ±29.24 |
Median (Range) | 340 | (190 - 540) | Median (Range) | 53.90 | (2 - 93.20) |
≤350 U/L | 23 | (51.1%) | <10% | 8 | (17.8%) |
>350 U/L | 22 | (48.9%) | >10% | 37 | (82.2%) |
B2-microglobulin (mg/L) |
|
| ZAP-70 |
|
|
Mean ± SD | 2.91 | ±0.99 | <20% | 27 | (60%) |
Median (Range) | 3 | (1.40 - 5) | >20% | 18 | (40%) |
<3.5 mg/L | 29 | (64.4%) | Time to begin ttt (months) for all Pt |
|
|
≥3.5 mg/L | 16 | (35.6%) | Mean ± SD | 5.07 | ±4.23 |
Coomb’s test |
|
| Median (Range) | 7 | (2 - 14) |
Negative | 38 | (84.4%) | Response* |
|
|
Positive | 7 | (15.6%) |
|
|
|
Lymphocytic doubling time (LDT) |
|
| No response (NR) | 19 | (42.2%) |
<12 months | 21 | (46.7%) | Overall response (ORR) | 20 | (44.5%) |
>12 months | 24 | (53.3%) |
|
|
|